Publications by authors named "Luke Andrew Ephraums"
Heart Lung Circ
November 2024
Article Synopsis
- Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are commonly used in treating heart failure (HF), but their association with ketosis risk during hospitalization is uncertain.
- A study measured ketone levels in hospitalized patients with worsening HF and stable HF to determine if SGLT2i use influenced ketone concentrations.
- Results showed that ketone levels were low across all patients, regardless of SGLT2i use or the severity of heart failure, indicating minimal risk of ketosis in these individuals.
